© Copyright. All rights reserved
OBERON: H2020 project coordinated by the SysTox group. The aim of the project is to build an integrated approach for testing and assessment (IATA) to detect endocrine disruptors-related metabolic disorders by developing, improving and validating a battery of test systems. Project part of the EURION cluster.
CREATIvE : ANR project coordinated by the SysTox group. Systems toxicology of pollutant mixture released from grafted adipose tissue.
MULTIMIX: ANR project – Multidisciplinary approach to better understand aroma perception of flavor mixture.
RadoNorm: H2020 project – Towards effective radiation protection based on improved scientific evidence and social considerations – focus on Radon and NORM
INCa et IRESP project: Co-exposure to cigarette smoke and tumor microenvironment & breast cancer aggressiveness.
Ecophyto II+ plan : Study of the effects from exposure to plant protection products on the cognitive and psychomotor development of children.
A self-questionnaire to enable researchers to assess the status of their in vitro test for endocrine disruptors.
The European Partnership for the Assessment of Risks from Chemicals aims to develop next-generation chemical risk assessment to protect human health and the environment. It supports the European Union’s Chemicals Strategy for Sustainability and the European Green Deal’s “Zero pollution” ambition.
iPOP-UP website is dedicated to host the shared knowledge of the Université Paris Cité bioinformatic community. It aims to gather tutorials, courses and presentations of events related to bioinformatics to make this field more accessible to students and researchers.
France Exposome supports research in the environmental health field, leading to a better understanding of the existing associations between chemical exposures and health outcomes related to chronic diseases.
HERA : H2020 project – The overall aim of the HERA project is to set the priorities for an envionment, climate and health reserach agenda in the EU.
HBM4EU: H2020 project with the aim of coordinating and advancing human biomonitoring in Europe to provide evidence for chemical policy making.